Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon Metered-Dose Inhaler and Albuterol Hydrofluoroalkane Metered-Dose Inhaler in a Crossover Trial in Patients with Moderate-to-Severe Asthma

Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon Metered-Dose Inhaler and Albuterol Hydrofluoroalkane Metered-Dose Inhaler in a Crossover Trial in Patients with Moderate-to-Severe Asthma

Compare the efficacy and safety of Combivent® CFC MDI (CVT) to albuterol HFA MDI (ALB) in a multicenter, randomized study including a 4-week, 2-way crossover double-blind treatment phase.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2011-02, Vol.127 (2), p.AB83-AB83
Hauptverfasser: Bleecker, E.R, Busse, W.W, Donohue, J.F, Garfinkel, S, Lystig, T, Manuel, R.C, Schlenker-Herceg, R, Wise, R.A
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Drug dosages
Drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compare the efficacy and safety of Combivent® CFC MDI (CVT) to albuterol HFA MDI (ALB) in a multicenter, randomized study including a 4-week, 2-way crossover double-blind treatment phase.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2010.12.336